The 13,600-Mile Remote Surgery, and Autozi's Wild SpaceX Play
I'm LongbridgeAI, I can summarize articles.SS Innovations broke records with a transcontinental remote surgery as its installations surged. Meanwhile, Autozi secured fresh funding to pivot toward SpaceX assets, and EON Resources kicked off a massive 92-well drilling program.
The Scoop: SS Innovations International (SSII.US) is fundamentally reshaping the physical limits of robotic healthcare. In mid-2026, the company successfully executed a 13,600-mile remote surgery connecting Colombia to India using its SSi Mantra system. This technical milestone is backed by rapid operational scaling: by early September, cumulative surgeries spiked 79% to over 14,000. Despite a slightly widened net loss of $2.7 million in Q2 2026, the company's 39% revenue growth to $13.9 million underscores the traction of its 238 global installations.
Over in the automotive tech sector, Autozi Internet Technology (AZI.US) is making aggressive and highly unusual moves. Facing a steep 63% revenue plunge to $29.5 million in H1 2026, the company still managed to secure a $30 million investment—with another $55 million in the works. The real twist? Autozi announced intentions to acquire significant economic exposure to SpaceX as a strategic treasury asset, all while actively negotiating a $320 million reverse merger.
On the traditional energy front, EON Resources (EONR.US) is aggressively pushing forward in the Permian Basin. The company just kicked off a 92-well horizontal drilling program, with the first wells expected to pump out $1 million in monthly net free cash flow by Q4 2026. However, they are simultaneously racing a six-month clock to regain NYSE compliance following a delayed 10-K filing. In related income-generating energy plays, the Defiance Oil Enhanced Options Income ETF (USOY.US) touted an eye-popping 45% expected dividend distribution rate this September.
Also:
- Tronox Holdings (TROX.US): The titanium dioxide heavy-hitter maintained its massive footprint, posting $3.06 billion in trailing 12-month revenue through mid-2026.
- SIGA Technologies (SIGA.US): The biopharma player behind the TPOXX antiviral declared a special $0.60 per share cash dividend, supported by $53.7 million in 12-month trailing revenue.
- UWM Holdings (UWMC.US), Pixelworks (PXLW.US), Box (BOX.US), and KIDZ.US have remained relatively quiet during this cycle, steering clear of major headline-making structural shifts.